In the Media
Are you looking for the latest media coverage of the BioMed X Institute, its research projects and people behind the innovation model? Here you will find the latest clippings – hot off the press!
Visit: BioMed X Institute and Healthcare Business of Merck KGaA, Darmstadt, Germany, Start New Research Project in Oncology
BioMed X Institute and Healthcare Business of Merck KGaA, Darmstadt, Germany, Start New Research Project in Oncology
PharmiWeb
Research team ‘EDC’ will study ‘Extrachromosomal DNA in Cancer’. With this project, the two partners launch their ninth collaboration, seven of which have been in the field of oncology.
Visit: BioMedX Initiates New Oncology Research Project with Merck
BioMedX Initiates New Oncology Research Project with Merck
Contract Pharma
BioMed X, a German independent research institute, has started its new research project ‘Extrachromosomal DNA in Cancer’ (EDC) in collaboration with Healthcare Business of Merck KGaA, Darmstadt, Germany. The main objective of this research group is to develop an atlas of extrachromosomal DNA (ecDNA) in human cancer tissues and thereby trace back the mechanisms of ecDNA formation and function.
Visit: Merck Healthcare Business, BioMed X Begin New Research Project in Oncology
Merck Healthcare Business, BioMed X Begin New Research Project in Oncology
Medical Dialogues
Germany. BioMed X, a German independent research institute, has announced the start of its new research project titled ‘Extrachromosomal DNA in Cancer’ (EDC) in collaboration with Healthcare Business of Merck KGaA, Darmstadt, Germany.
Visit: BioMed X Institute Enters New Collaboration with Merck
BioMed X Institute Enters New Collaboration with Merck
The Pharma Letter
German independent research institute BioMed X has announced the start of its new research project ‘Extrachromosomal DNA in Cancer’ (EDC) in collaboration with the Healthcare Business of Germany’s Merck KGaA, Darmstadt. The main objective of this research group is to develop an atlas of extrachromosomal DNA (ecDNA) in human cancer tissues and thereby trace back the mechanisms of ecDNA formation…
Visit: BioMed X Institute and Merck Start New Oncology Research Project
BioMed X Institute and Merck Start New Oncology Research Project
Labiotech.eu
BioMed X, a German independent research institute, has started a new research project ‘Extrachromosomal DNA in Cancer’ (EDC) in collaboration with the Healthcare Business of Merck KGaA, Darmstadt, Germany. The main objective of this research group is to develop an atlas of extrachromosomal DNA (ecDNA) in human cancer tissues and trace back the mechanisms of ecDNA formation and function.